The accused products are light bulbs containing filament LEDs with ceramic submounts, and filament LEDs with flexible surfaces.

On March 30, 2021, the ITC issued a Notice of Investigation in Certain Smart Thermostat Systems, Smart HVAC Systems, Smart HVAC Control Systems, and Components Thereof (Inv. No. 337-TA-1258).

On July 21, 2021, the ITC issued a Notice of Investigation in Certain Integrated Circuits and Products Containing Same (Inv. No. 337-TA-1272).

On November 4, 2021, the ITC issued a Notice of Investigation in Certain Oil-Vaping Cartridges, Components Thereof, and Products Containing the Same.

On December 1, 2021, the ITC issued a Notice of Investigation in Certain Integrated Circuits, Chipsets, and Electronic Devices, and Products Containing the Same (Inv. No. 337-TA-1287).

On February 17, 2022, the ITC issued a Notice of Investigation in Certain Mobile Telephones, Tablet Computers With Cellular Connectivity, and Smart Watches With Cellular Connectivity, ...

On February 17, 2022, the ITC issued a Notice of Investigation in Certain Mobile Phones, Tablet Computers, Smart Watches, Smart Speakers, and Digital Media Players, and Products Containing Same (Inv. No. 337-TA-1300).

On April 1, 2022, the ITC issued a Notice of Investigation in Certain Interactive Fitness Products Including Stationary Bikes, Treadmills, Elliptical Machines, and Rowing Machines...

On June 21, 2022, the ITC issued a Notice of Investigation in Certain Universal Golf Club Shaft and Golf Club Head Connection Adaptors, Certain Components Thereof, and Products Containing the Same (Inv. No. 337-TA-1320).

On March 30, 2022, Medytox Inc. of the Republic of Korea ("Medytox") filed a complaint requesting that the ITC commence an investigation pursuant to section 337.

On April 23 President Biden signed into law changes narrowing the scope of eligibility for the non-patent "new chemical entity" (NCE) 5-year exclusivity provisions of 21 U.S.C.

Historically, patent infringement judgments in U.S. federal courts led almost automatically to injunctive relief under 35 USC 283. This section of the patent statute provides that a court...

Two of the decisions are related to when live testimony is allowed during oral arguments.

The PTAB designated three decisions as precedential yesterday (in addition to several in previous weeks).

Federal Circuit applied Amgen v. Sanofi, 598 U.S. 594 (2013)in deciding that claims 1-4, 19 and 20 of Baxalta's hemophilia patent, U.S. Patent 7,033,590 (‘590)...

The United States Patent and Trademark Office (USPTO) today announced a collaborative deferred-fee provisional patent application pilot program for inventions that combat COVID-19.

On Wednesday, July 1, 2020, the USPTO issued a release stating: The United States Patent and Trademark Office (USPTO) today announced plans for the Patent Trial and Appeal Board (PTAB)...

On June 15, 2023, the U.S. Patent and Trademark Office (USPTO) issued a final rule on the filing of a Patent Term Adjustment (PTA) statement regarding an Information Disclosure Statement (IDS).

To accelerate innovation in the health and medical fields, the USPTO published a Federal Register Notice announcing a fifth extension of its Cancer Immunotherapy Pilot Program.

On June 9, 2022, the USPTO issued updated guidance on the use of applicant admitted prior art (AAPA) in IPR proceedings, expanding upon a similar memorandum issued under prior Director Iancu.